Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kahira Pharmaceutical & Chemical Industries is a leading Egyptian pharmaceutical manufacturer established in 1962 and headquartered in Cairo. As a subsidiary of the state-owned Holding Company for Pharmaceuticals, Chemicals and Medical Appliances (HoldiPharma), it operates as a major player in the Middle Eastern and African healthcare markets. The company specializes in the production of a diverse range of human and veterinary medicines, including antibiotics, analgesics, and treatments for chronic conditions, as well as cosmetics and chemicals. Kahira Pharma is publicly traded on the Egyptian Exchange and maintains significant manufacturing facilities that produce various dosage forms such as tablets, capsules, syrups, and ointments. In addition to its own product line, the company provides contract manufacturing services for several multinational pharmaceutical firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kahira Pharmaceutical & Chemical Industries.